Table of Contents

2019-2024 Global Recombinant Trypsin Solution Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Recombinant Trypsin Solution Consumption 2014-2024
  • 2.1.2 Recombinant Trypsin Solution Consumption CAGR by Region
• 2.2 Recombinant Trypsin Solution Segment by Type
  • 2.2.1 Solid
  • 2.2.2 Liquid
• 2.3 Recombinant Trypsin Solution Consumption by Type
  • 2.3.1 Global Recombinant Trypsin Solution Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Recombinant Trypsin Solution Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Recombinant Trypsin Solution Sale Price by Type (2014-2019)
• 2.4 Recombinant Trypsin Solution Segment by Application
  • 2.4.1 Insulin Manufacturing
  • 2.4.2 Vaccines Manufacturing
  • 2.4.3 Cell Culture
  • 2.4.4 Other
• 2.5 Recombinant Trypsin Solution Consumption by Application
  • 2.5.1 Global Recombinant Trypsin Solution Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Recombinant Trypsin Solution Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Recombinant Trypsin Solution Sale Price by Application (2014-2019)

3 Global Recombinant Trypsin Solution by Players

• 3.1 Global Recombinant Trypsin Solution Sales Market Share by Players
  • 3.1.1 Global Recombinant Trypsin Solution Sales by Players (2017-2019)
  • 3.1.2 Global Recombinant Trypsin Solution Sales Market Share by Players (2017-2019)
• 3.2 Global Recombinant Trypsin Solution Revenue Market Share by Players
  • 3.2.1 Global Recombinant Trypsin Solution Revenue by Players (2017-2019)
  • 3.2.2 Global Recombinant Trypsin Solution Revenue Market Share by Players (2017-2019)
• 3.3 Global Recombinant Trypsin Solution Sale Price by Players
• 3.4 Global Recombinant Trypsin Solution Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Recombinant Trypsin Solution Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Recombinant Trypsin Solution Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Recombinant Trypsin Solution by Regions

• 4.1 Recombinant Trypsin Solution by Regions
  • 4.1.1 Global Recombinant Trypsin Solution Consumption by Regions
  • 4.1.2 Global Recombinant Trypsin Solution Value by Regions
• 4.2 Americas Recombinant Trypsin Solution Consumption Growth
• 4.3 APAC Recombinant Trypsin Solution Consumption Growth
• 4.4 Europe Recombinant Trypsin Solution Consumption Growth
• 4.5 Middle East & Africa Recombinant Trypsin Solution Consumption Growth

5 Americas

• 5.1 Americas Recombinant Trypsin Solution Consumption by Countries
  • 5.1.1 Americas Recombinant Trypsin Solution Consumption by Countries (2014-2019)
  • 5.1.2 Americas Recombinant Trypsin Solution Value by Countries (2014-2019)
• 5.2 Americas Recombinant Trypsin Solution Consumption by Type
• 5.3 Americas Recombinant Trypsin Solution Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Recombinant Trypsin Solution Consumption by Countries
  • 6.1.1 APAC Recombinant Trypsin Solution Consumption by Countries (2014-2019)
  • 6.1.2 APAC Recombinant Trypsin Solution Value by Countries (2014-2019)
• 6.2 APAC Recombinant Trypsin Solution Consumption by Type
• 6.3 APAC Recombinant Trypsin Solution Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Recombinant Trypsin Solution by Countries
  • 7.1.1 Europe Recombinant Trypsin Solution Consumption by Countries (2014-2019)
  • 7.1.2 Europe Recombinant Trypsin Solution Value by Countries (2014-2019)
• 7.2 Europe Recombinant Trypsin Solution Consumption by Type
• 7.3 Europe Recombinant Trypsin Solution Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Recombinant Trypsin Solution by Countries
  • 8.1.1 Middle East & Africa Recombinant Trypsin Solution Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Recombinant Trypsin Solution Value by Countries (2014-2019)
• 8.2 Middle East & Africa Recombinant Trypsin Solution Consumption by Type
• 8.3 Middle East & Africa Recombinant Trypsin Solution Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Recombinant Trypsin Solution Distributors
• 10.3 Recombinant Trypsin Solution Customer

11 Global Recombinant Trypsin Solution Market Forecast

• 11.1 Global Recombinant Trypsin Solution Consumption Forecast (2019-2024)
• 11.2 Global Recombinant Trypsin Solution Forecast by Regions
  • 11.2.1 Global Recombinant Trypsin Solution Forecast by Regions (2019-2024)
  • 11.2.2 Global Recombinant Trypsin Solution Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Recombinant Trypsin Solution Forecast by Type
• 11.8 Global Recombinant Trypsin Solution Forecast by Application

12 Key Players Analysis

• 12.1 Novozymes
  • 12.1.1 Company Details
  • 12.1.2 Recombinant Trypsin Solution Product Offered
  • 12.1.3 Novozymes Recombinant Trypsin Solution Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Novozymes News
• 12.2 Thermo Fisher
  • 12.2.1 Company Details
  • 12.2.2 Recombinant Trypsin Solution Product Offered
  • 12.2.3 Thermo Fisher Recombinant Trypsin Solution Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 Thermo Fisher News
• 12.3 Roche
  • 12.3.1 Company Details
  • 12.3.2 Recombinant Trypsin Solution Product Offered
  • 12.3.3 Roche Recombinant Trypsin Solution Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 Roche News
• 12.4 BBI Group
  • 12.4.1 Company Details
  • 12.4.2 Recombinant Trypsin Solution Product Offered
  • 12.4.3 BBI Group Recombinant Trypsin Solution Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 BBI Group News
• 12.5 Merck
  • 12.5.1 Company Details
  • 12.5.2 Recombinant Trypsin Solution Product Offered
  • 12.5.3 Merck Recombinant Trypsin Solution Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 Merck News
• 12.6 Biological Industries
  • 12.6.1 Company Details
  • 12.6.2 Recombinant Trypsin Solution Product Offered
  • 12.6.3 Biological Industries Recombinant Trypsin Solution Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 Biological Industries News
• 12.7 Yaxin Bio
  • 12.7.1 Company Details
  • 12.7.2 Recombinant Trypsin Solution Product Offered
  • 12.7.3 Yaxin Bio Recombinant Trypsin Solution Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 Yaxin Bio News
• 12.8 Lonza
  • 12.8.1 Company Details
  • 12.8.2 Recombinant Trypsin Solution Product Offered
  • 12.8.3 Lonza Recombinant Trypsin Solution Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.8.4 Main Business Overview
  • 12.8.5 Lonza News
• 12.9 Yocon Hengye Bio
  • 12.9.1 Company Details
  • 12.9.2 Recombinant Trypsin Solution Product Offered
  • 12.9.3 Yocon Hengye Bio Recombinant Trypsin Solution Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.9.4 Main Business Overview
  • 12.9.5 Yocon Hengye Bio News
• 12.10 Biosera
  • 12.10.1 Company Details
  • 12.10.2 Recombinant Trypsin Solution Product Offered
  • 12.10.3 Biosera Recombinant Trypsin Solution Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.10.4 Main Business Overview
  • 12.10.5 Biosera News
• 12.11 BasalMedia
• 12.12 Solarbio

13 Research Findings and Conclusion

Recombinant Trypsin is a genetically engineered protein expressed in E-Coli. As such it is totally animal free, free from contaminating enzymes like chymotrysin as well as protease inhibitors. It is highly stable with a high purity. It is widely used in insulin manufacturing, Vaccines Manufacturing and cell culture applications.
North American is the largest consumption place, with a consumption market share nearly 42.75% in 2017. Following North American, Europe is the second largest consumption place with the consumption market share of 31.56%.

According to this study, over the next five years the Recombinant Trypsin Solution market will register a 7.1% CAGR in terms of revenue, the global market size will reach US$ 56 million by 2024, from US$ 40 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Recombinant Trypsin Solution business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Recombinant Trypsin Solution market by product type, application, key manufacturers and key regions and countries.

This study considers the Recombinant Trypsin Solution value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Solid
Liquid
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Insulin Manufacturing
Vaccines Manufacturing
Cell Culture
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Novozymes
Thermo Fisher
Roche
BBI Group
Merck
Biological Industries
Yaxin Bio
Lonza
Yocon Hengye Bio
Biosera
BasalMedia
Solarbio

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Recombinant Trypsin Solution consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Recombinant Trypsin Solution market by identifying its various subsegments.
Focuses on the key global Recombinant Trypsin Solution manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Recombinant Trypsin Solution with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Recombinant Trypsin Solution submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.